May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
Cormorant Asset Management's exit from Arcellx, involving the sale of 775,000 shares, sparked curiosity about timing and strategic shifts. The impact on biotech investment strategies could ripple wider.